National Institute of Environmental Health Sciences; Notice of Closed Meetings, 14670-14671 [2024-04110]

Download as PDF 14670 Federal Register / Vol. 89, No. 40 / Wednesday, February 28, 2024 / Notices Requests to participate as a speaker must include all of the following information: 1. The name and email address of the person desiring to participate 2. The organization(s) that person represents, if any 3. The document(s) and primary article(s) of interest, listed in order of the speaker’s priorities Other Information: Written comments should be emailed to oga.rsvp@hhs.gov with the subject line ‘‘Written Comment Re: Stakeholder Listening Session on public health emergencies preparedness and response negotiations’’ by Wednesday, April 17, 2024. We look forward to your comments on these matters. Dated: February 22, 2024. Susan Kim, Principal Deputy Assistant Secretary. [FR Doc. 2024–04080 Filed 2–27–24; 8:45 am] BILLING CODE 4150–38–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing AGENCY: National Institutes of Health, HHS. ACTION: Notice. The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. FOR FURTHER INFORMATION CONTACT: Wade Green at (301) 761–7505 or greenww@nih.gov. Licensing information may be obtained by communicating with the Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases, 5601 Fishers Lane, Rockville, MD 20852: tel. 301–496– 2644. A signed Confidential Disclosure Agreement will be required to receive copies of unpublished information related to the invention. SUPPLEMENTARY INFORMATION: Technology description follows: An Innovative Adapter for Expedited and Automated Thawing of viably Frozen Cells. ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 19:59 Feb 27, 2024 Jkt 262001 Description of Technology This technology is a device and system for expediting the thawing frozen specimens (e.g., cryopreserved cells) contained in cryo-vials, offering a breakthrough solution for researchers seeking efficiency and precision in their workflows. The device is equipped with a small elongated tubular adaptor that suspends a cryo-vial of frozen cells over a centrifuge tube containing culture medium in an inverted position. With a focus on speed, efficiency and automation, the adaptor dramatically expedites the process of recovering viable cells from frozen specimens. It reduces per-sample labor time for thawing from several minutes to a few seconds, enabling a single technician to simultaneously thaw multiple vials within the capacity of centrifuges. The cells, once thawed, are diluted instantly into growth medium contained in the centrifuge tubes and spend essentially no time in liquid cryopreservative. The automated mechanism ensures a precise and controlled thawing environment maintaining optimal temperature conditions throughout the thawing process. Potential Commercial Applications: • This device can be used in sample preparation and cell culturing. • Applicable for research materials, medical and non-medical devices and consumer products. Competitive Advantages: • Provides a faster process of recovering viable cells from frozen specimens. • Eliminates multi-step processes. • High throughput system with reduced variability. • Constant environment control. Development Stage: • Prototype Inventors: Dr. Mario Roederer, Dr. Pratip Chattopadhyay and Margaret Beddall, all of NIAID. Publications: n/a. Intellectual Property: HHS Reference No. E–080–2015–0–EIR–00 U.S. Patent Application No. 14/661,449, filed on March 18, 2015; Published Patent Application US20160274004A1 on September 22, 2016; U.S. Patent 9,663,812 issued May 30, 2017. Licensing Contact: To license this technology, please contact Wade Green at (301) 761–7505 or greenww@nih.gov. and reference E–080–2015. Collaborative Research Opportunity: The National Institute of Allergy and Infectious Diseases is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize this technology. For PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 collaboration opportunities, please contact Wade Green at (301) 761–7505 or greenww@nih.gov. Dated: February 7, 2024. Surekha Vathyam, Deputy Director, Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases. [FR Doc. 2024–04060 Filed 2–27–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Career Development in K Applications. Date: March 20–21, 2024. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Environmental Health Science, 530 Davis Drive, Keystone Building, Durham, NC 27713 (Virtual Meeting). Contact Person: Beverly W. Duncan, Ph.D., Scientific Review Officer, Division of Extramural Research and Training, National Institute of Environmental Health Science, Keystone Building, 530 Davis Drive, Room 3130, Durham, NC 27713, (240) 353–6598, beverly.duncan@nih.gov. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Exposome Research Coordination to Accelerate Precision Environmental Health (PEH). Date: April 3, 2024. Time: 10:30 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Environmental Health Science, 530 Davis Drive, Keystone Building, Durham, NC 27713 (Virtual Meeting). Contact Person: Leroy Worth, Ph.D., Scientific Review Officer, Scientific Review E:\FR\FM\28FEN1.SGM 28FEN1 Federal Register / Vol. 89, No. 40 / Wednesday, February 28, 2024 / Notices Branch, Division of Extramural Research and Training, Nat. Institute of Environmental Health Sciences, P.O. Box 12233, MD EC–30/ Room 3171, Research Triangle Park, NC 27709, (984) 287–3340, worth@niehs.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: February 22, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–04110 Filed 2–27–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting ddrumheller on DSK120RN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; State Dementia Care Research Center. Date: March 25, 2024. Time: 10:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Sandhya Sanghi, Ph.D., Scientific Research Officer, Scientific Review Branch, National Institute on Aging, 7201 Wisconsin Avenue, Gateway Bldg., Suite 2N230, (301) 496–2879, sandhya.sanghi@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) VerDate Sep<11>2014 19:59 Feb 27, 2024 Jkt 262001 Dated: February 22, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–04111 Filed 2–27–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel, PAR–22–102 and PAR– 22–103: Investigational New Drug (IND)—enabling and Early-Stage Development of Medications to Treat Alcohol Use Disorder and AlcoholAssociated Organ Damage March 21, 2024, 01:00 p.m. to March 21, 2024, 04:00 p.m., National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on February 01, 2024, FR Doc 2024–01998, 89 FR 6530. This notice is being amended to change the Meeting Format from a Regular Meeting to a Virtual Meeting. The meeting is closed to the public. Dated: February 21, 2024. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–04115 Filed 2–27–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Advisory Committee on Research on Women’s Health. The meeting will be open to the public as a virtual meeting. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov/). PO 00000 Frm 00050 Fmt 4703 Sfmt 9990 14671 Name of Committee: Advisory Committee on Research on Women’s Health. Date: April 9, 2024. Time: 9:30 a.m. to 4:00 p.m. Agenda: ORWH Director’s Report, Panel discussion on the middle life health of women and menopause, Presentation from NIH Director, Presentation of three concepts for Advisory Committee clearance including NIH Office of Autoimmune Disease Research in ORWH (OADR–ORWH) and the NIH-Wide Women’s Health Funding Opportunity. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Hybrid Meeting). Contact Person: Vivian Ota Wang, Ph.D., FACMG, CGC, Deputy Director, Office on Research for Women’s Health, Division of Program Coordination, Planning and Strategic Initiatives, National Institutes of Health, 6707 Democracy Blvd., Bethesda, MD 20892, 240–550–9892, otawangv@nih.gov, samia.noursi@nih.gov. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meetings. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// orwh.od.nih.gov/, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: February 22, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–04108 Filed 2–27–24; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\28FEN1.SGM 28FEN1

Agencies

[Federal Register Volume 89, Number 40 (Wednesday, February 28, 2024)]
[Notices]
[Pages 14670-14671]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04110]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Environmental Health Sciences; Notice of 
Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Environmental Health 
Sciences Special Emphasis Panel; Career Development in K 
Applications.
    Date: March 20-21, 2024.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Environmental Health Science, 530 
Davis Drive, Keystone Building, Durham, NC 27713 (Virtual Meeting).
    Contact Person: Beverly W. Duncan, Ph.D., Scientific Review 
Officer, Division of Extramural Research and Training, National 
Institute of Environmental Health Science, Keystone Building, 530 
Davis Drive, Room 3130, Durham, NC 27713, (240) 353-6598, 
[email protected].

    Name of Committee: National Institute of Environmental Health 
Sciences Special Emphasis Panel; Exposome Research Coordination to 
Accelerate Precision Environmental Health (PEH).
    Date: April 3, 2024.
    Time: 10:30 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Environmental Health Science, 530 
Davis Drive, Keystone Building, Durham, NC 27713 (Virtual Meeting).
    Contact Person: Leroy Worth, Ph.D., Scientific Review Officer, 
Scientific Review

[[Page 14671]]

Branch, Division of Extramural Research and Training, Nat. Institute 
of Environmental Health Sciences, P.O. Box 12233, MD EC-30/Room 
3171, Research Triangle Park, NC 27709, (984) 287-3340, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.115, 
Biometry and Risk Estimation--Health Risks from Environmental 
Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety 
Training; 93.143, NIEHS Superfund Hazardous Substances--Basic 
Research and Education; 93.894, Resources and Manpower Development 
in the Environmental Health Sciences; 93.113, Biological Response to 
Environmental Health Hazards; 93.114, Applied Toxicological Research 
and Testing, National Institutes of Health, HHS)

    Dated: February 22, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-04110 Filed 2-27-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.